Principal Financial Group
DNA icon

Principal Financial Group’s Ginkgo Bioworks DNA Stock Holding History

Principal Financial Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,308
Closed -$153K – 2395
2024
Q1 		$153K Buy
3,308
+555
+20% +$28.7K ﹤0.01% 2216
2023
Q4 		$186K Sell
2,753
-505
-16% -$30.9K ﹤0.01% 2181
2023
Q3 		$236K Buy
3,258
+187
+6% +$15K ﹤0.01% 2120
2023
Q2 		$228K Buy
3,071
+849
+38% +$50.3K ﹤0.01% 2145
2023
Q1 		$118K Buy
2,222
+20
+0.9% +$1.27K ﹤0.01% 2278
2022
Q4 		$149K Sell
2,202
-3,588
-62% -$330K ﹤0.01% 2242
2022
Q3 		$722K Buy
5,790
+133
+2% +$15.8K ﹤0.01% 1891
2022
Q2 		$538K Buy
+5,657
New +$690K ﹤0.01% 2039

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Principal Financial Group's DNA Position: Q2 2024 in Review

Principal Financial Group sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 3,308 shares — an estimated $153K sold.

Principal Financial Group first reported a position in DNA in Q2 2022 and held it in 8 quarters. The position peaked at $722K in Q3 2022. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Principal Financial Group reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 3,308 Ginkgo Bioworks shares in Q2 2024, an estimated $153K.
  • Principal Financial Group first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 8 quarters.
  • Principal Financial Group's Ginkgo Bioworks position peaked at $722K in Q3 2022.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.